News about PaperPanda, Open Access, and Research
By Michael Le Page An illustration of a strand of mRNA MattLphotography / Alamy Stock Photo Immune cells in the bodies of mice have been temporarily reprogrammed to repair damaged hearts by removing scar tissue, thanks to the technology used in the mRNA coronavirus vaccines. “After you give the treatment, the scar goes away,” says … Read more
While the Omicron variant spreads across the world and major producers of COVID vaccines squabble over granting global access, a vaccine developed by the Texas Children’s Hospital Center for Vaccine Development (Texas Children’s CVD) and Baylor College of Medicine is ready to be deployed. In the last week of 2021, India’s drug regulation agency authorized … Read more
Scientists are working hard to make pet-related sneezes and sniffles a distant memory, and there’s promising news from researchers analyzing the potential for a vaccine against dog allergies. In what’s being described as a first step in developing such a vaccine, a team in Japan has identified certain parts of molecules that may be … Read more
With booster jabs forming the backbone of the UK’s omicron efforts, it’s more important than ever to reach out to pregnant women and people from ethnic minority groups who may be more likely to have concerns over vaccination Health | Analysis 24 December 2021 By Jason Arunn Murugesu A mass vaccination hub at Stamford Bridge … Read more
Editor’s Note (12/21/21): This article is being showcased in a special collection about equity in health care that was made possible by the support of Takeda. The article was published independently and without sponsorship. As the U.S. and U.K. vaccinate their populations much faster than initially anticipated, two disparate concepts have been swirling online in … Read more
The small Maryland biotechnology company Novavax has finally joined the ranks of high-profile COVID-19 vaccine developers after winning emergency authorizations in recent days for its candidate. The decisions by the World Health Organization (WHO) and the European Commission make the company’s product the first protein-based vaccine green-lighted by those bodies and opens it to broad … Read more
October saw the RTS,S malaria vaccine given the go-ahead for use outside trials for the first time – a momentous decision, decades in the making Health 15 December 2021 By Clare Wilson REUTERS/James Keyi/Alamy Decades in the making, October saw a malaria vaccine given the go-ahead for use outside trials for the first time, described … Read more
US vaccine maker Moderna expressed confidence Monday that its booster shot was effective against the Omicron variant, after the announcement of laboratory results it described as “reassuring”. “We’ll be able to rely on this vaccine to address the near term surge of Omicron cases,” Stephen Hoge, president of Moderna, said on a conference call. … Read more
After facing setback after setback this year, the nonprofit formed to make sure COVID-19 vaccines reach the poorest countries of the world may finally live up to its promise in 2022. A 14 December report shows that after scaling back its ambitions, the COVID-19 Vaccines Global Access (COVAX) Facility is close to meeting a revised … Read more
By Michael Le Page, Clare Wilson, Jessica Hamzelou, Sam Wong, Graham Lawton, Adam Vaughan, Conrad Quilty-Harper, Jason Arunn Murugesu and Layal Liverpool A pregnant woman with a plaster on her arm aire images/Getty Images Latest coronavirus news as of 11am on 17 December UK vaccine committee urges pregnant women to book jabs Pregnant women should … Read more